Mineralys Therapeutics Inc (MLYS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mineralys Therapeutics Inc   (NASDAQ: MLYS)


Mineralys Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Mineralys Therapeutics Inc 's ROA in the second quarter of 2026?
Mineralys Therapeutics Inc recorded a cumulative net loss of $-350 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -53.92%.

However, within the Healthcare sector 579 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3583, from total ROA ranking in the first quarter of 2026 at 4301.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 102.17 % 83.94 % 221.42 % 123.65 % 5.41 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -350 -152 -155 -171 -191
Return On Assets (TTM) -53.92 % -26.98 % -31.68 % -45.8 % -65.51 %
MLYS's Total Ranking # 3583 # 4301 # 3982 # 4239 # 4321
Total Assets (TTM) in million 679 653 662 600 336
Seq. Total Assets Change 3.96 % -1.35 % 10.31 % 78.7 % -5.41 %
Seq. Net Income Change - - - - -

MLYS's 5 Years Annual ROA >> Back to MLYS Management Effectiveness >> Compare MLYS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 255
Sector # 580
Overall # 3933

Return On Assets Statistics
High Average Low
-25.52 %
-45.51 %
-65.71 %
(Dec 31 2023)   (Mar 31 2025)





Financial Statements
Mineralys Therapeutics Inc 's Assets $ 679 million MLYS's Balance sheet
Mineralys Therapeutics Inc 's Income $ -241 million Quarterly MLYS's Income Statement
MLYS's Income by Division See MLYS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023
FY
FY
Y / Y Total Assets Change 221.42 % -18 % - - -
Total Assets in million 662 206 251 0 0
Y / Y Net Income Change - - - - -
Net Income in million -155 -178 -72 0 0
Annual Return On Assets -23.37 % -86.36 % -28.63 % - -

MLYS's 5 Years Annual ROA >> Back to MLYS Management Effectiveness >> Compare MLYS ROA to its Competitors



More Return On Assets Ratios
MLYS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MLYS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MLYS's Competitors
Subscribers only: Roa for Mineralys Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for MLYS's Customers

You may also want to know
MLYS's Roi MLYS's Inventory Turnover Ratio MLYS's Growth Rates MLYS's Dividend Comparisons
MLYS's Profitability Ratios MLYS's Asset Turnover Ratio MLYS's Dividend Growth
MLYS's Roe MLYS's Valuation Ratios MLYS's Financial Strength Ratios MLYS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T21:02:24+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.